Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study

Previously, we synthesized triazoloquinazolines 1–14 and characterized their structure. In this study, we aimed to evaluate the in vitro activity of the targets 1–14 as α-glucosidase inhibitors using α-glucosidase enzyme from Saccharomyces cerevisiae type 1. Among the tested compounds, triazoloquina...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuelizz, Hatem A., Anouar, El Hassane, Ahmad, Rohaya, Azman, Nor Izzati Iwana Nor, Marzouk, Mohamed, Al-Salahi, Rashad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693780/
https://www.ncbi.nlm.nih.gov/pubmed/31412050
http://dx.doi.org/10.1371/journal.pone.0220379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693780/
https://www.ncbi.nlm.nih.gov/pubmed/31412050
http://dx.doi.org/10.1371/journal.pone.0220379

Ejemplares similares